HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition-Reference-Cited by-同舟云学术

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition

Published:2018-05-21 Issue:6 Volume:24 Page:847-856
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Vaccari Monica,Fourati Slim^ORCID,Gordon Shari N.,Brown Dallas R.,Bissa Massimilano,Schifanella Luca,Silva de Castro Isabela,Doster Melvin N.,Galli Veronica,Omsland Maria,Fujikawa Dai,Gorini Giacomo,Liyanage Namal P. M.,Trinh Hung V.,McKinnon Katherine M.,Foulds Kathryn E.,Keele Brandon F.,Roederer Mario,Koup Richard A.,Shen Xiaoying,Tomaras Georgia D.,Wong Marcus P.,Munoz Karissa J.,Gach Johannes S.,Forthal Donald N.,Montefiori David C.,Venzon David J.,Felber Barbara K.,Rosati Margherita,Pavlakis George N.,Rao Mangala,Sekaly Rafick-Pierre,Franchini Genoveffa

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0025-7.pdf

Reference75 articles.

1. Pitisuttithum, P. et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194, 1661–1671 (2006).

2. Gray, G. E. et al. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect. Dis. 11, 507–515 (2011).

3. Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881–1893 (2008).

4. Hammer, S. M. et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N. Engl. J. Med. 369, 2083–2092 (2013).

5. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209–2220 (2009).

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition;Frontiers in Immunology;2024-09-05

2. Hypoxia activates macrophage‐NLRP3 inflammasome promoting atherosclerosis via PFKFB3‐driven glycolysis;The FASEB Journal;2024-08-03

3. Editorial: Vaccine-induced innate immunity and its role in viral infections;Frontiers in Immunology;2024-07-11

4. Novel Oral Adjuvant to Enhance Cytotoxic Memory-Like NK Cell Responses in an HIV Vaccine Platform;2024-06-19

5. Novel Oral Adjuvant to Enhance Cytotoxic Memory-Like NK Cell Responses in an HIV Vaccine Platform;2024-05-14